Cargando…
A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects
OBJECTIVES: To evaluate the analgesic/antihyperalgesic effect of ASP8477. DESIGN: Randomized, double-blind, double-dummy, cross-over, placebo- and active comparator-controlled study. SETTING: HPR Dr. Schaffler GmbH, Munich, Germany. SUBJECTS: Healthy female subjects aged 18–65 years. METHODS: Eligib...
Autores principales: | Schaffler, Klaus, Yassen, Ashraf, Reeh, Peter, Passier, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998989/ https://www.ncbi.nlm.nih.gov/pubmed/29228247 http://dx.doi.org/10.1093/pm/pnx281 |
Ejemplares similares
-
The MOBILE Study—A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain
por: Bradford, Daniel, et al.
Publicado: (2017) -
A Phase I, Randomized, Double-Blind, Laser-Evoked Potential Study to Evaluate the Analgesic/Antihyperalgesic Effect of ASP9226, a State-Dependent N-Type Voltage-Gated Calcium Channel Inhibitor, in Healthy Male Subjects
por: Schaffler, Klaus, et al.
Publicado: (2018) -
A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia
por: Oka, Hiroshi, et al.
Publicado: (2020) -
A Cocktail Interaction Study Evaluating the Drug‐Drug Interaction Potential of the Perpetrator Drug ASP8477 at Multiple Ascending Dose Levels
por: Treijtel, Nicoline, et al.
Publicado: (2019) -
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective Na(V)1.8 Inhibitor, in Healthy Male Adults
por: Hijma, Hemme J, et al.
Publicado: (2021)